NCT06788418 Comparative Study of SMILE, ICL, and Wavelight Plus Alcon Technologies in Myopia Correction
| NCT ID | NCT06788418 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Visionly Plus Eye Hospital |
| Condition | Myopia |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-01-20 |
| Primary Completion | 2025-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Myopia is a prevalent refractive error with significant lifestyle impact. While traditional SMILE (Small Incision Lenticule Extraction) and ICL (Implantable Collamer Lens) surgeries are standard options, the advent of the Wavelight Plus Alcon system presents a promising new technique. This trial aims to evaluate the safety, efficacy, and patient satisfaction across these methods.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18-40 years * Spherical equivalent of -1.00 to -10.00 D * Stable refraction for at least 12 months * Informed consent provided Exclusion Criteria: * Other ocular pathologies * Previous refractive surgery * Pregnancy or nursing * Autoimmune or connective tissue disorders